Taiki Mihara
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
COX2+/PDGFRα+ fibroblasts selectively localize near bile ducts and interact with immune cells in early liver fibrosis in mice.
Journal: Physiological reports
Published: March 09, 2026
MASH-induced elevation of FGF23 promotes hepatic osteodystrophy.
Journal: Bone
Published: November 16, 2025
Delayed Upper Gastrointestinal Motility in Mice Treated with Oral Iron Tablets.
Journal: Biological & pharmaceutical bulletin
Published: April 23, 2025
Pemigatinib suppresses liver fibrosis and subsequent osteodystrophy in mice.
Journal: Hepatology communications
Published: July 11, 2024
Intestinal Dysmotility and Associated Disorders in Intestinal Muscle of Methylglyoxal-Treated Mice.
Journal: Neurogastroenterology and motility
Published: March 28, 2024
Dasatinib promotes muscle differentiation and disrupts normal muscle regeneration.
Journal: International journal of medical sciences
Published: February 01, 2024
Nicotine aggravates liver fibrosis via α7 nicotinic acetylcholine receptor expressed on activated hepatic stellate cells in mice.
Journal: Hepatology communications
Published: October 13, 2023
Purinergic P2X7 receptor antagonist ameliorates intestinal inflammation in postoperative ileus.
Journal: The Journal of veterinary medical science
Published: March 07, 2022
Npr2 mutant mice show vasodilation and undeveloped adipocytes in mesentery.
Journal: BMC research notes
Published: September 08, 2021
Liver fibrosis-induced muscle atrophy is mediated by elevated levels of circulating TNFα.
Journal: Cell death & disease
Published: June 12, 2020
The anti-inflammatory pathway regulated via nicotinic acetylcholine receptors in rat intestinal mesothelial cells.
Journal: The Journal of veterinary medical science
Published: September 22, 2017
Last Updated: 09/26/2026